HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoli Lou Selected Research

E2F3 Transcription Factor

5/2021Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoli Lou Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 12/2016
2Sepsis (Septicemia)
12/2018 - 02/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021
1Lung Neoplasms (Lung Cancer)
05/2021
1Lymphoma (Lymphomas)
01/2021
1Triple Negative Breast Neoplasms
01/2020
1Brain Edema (Cerebral Edema)
01/2020
1Brain Injuries (Brain Injury)
01/2020
1Cerebral Hemorrhage
01/2020
1Hematoma
01/2020
1Neoplasm Metastasis (Metastasis)
09/2017
1Esophageal Neoplasms (Esophageal Cancer)
09/2017
1Body Weight (Weight, Body)
02/2017
1Melanoma (Melanoma, Malignant)
12/2016
1Inflammation (Inflammations)
11/2015
1Peripheral Nervous System Diseases (PNS Diseases)
01/2015
1Myocardial Infarction
01/2015
1Chronic Hepatitis B
01/2013
1Pain (Aches)
09/2012
1Hypersensitivity (Allergy)
09/2012
1Hyperalgesia
09/2012

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
05/2021 - 09/2012
3Messenger RNA (mRNA)IBA
05/2021 - 02/2017
3Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2015
2CytokinesIBA
01/2020 - 09/2012
2Toll-Like Receptor 4IBA
01/2015 - 09/2012
1Pharmaceutical PreparationsIBA
01/2022
1E2F Transcription FactorsIBA
05/2021
1E2F3 Transcription FactorIBA
05/2021
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
01/2021
1CaspasesIBA
11/2020
1Fas Ligand Protein (Fas Ligand)IBA
11/2020
1Hematoxylin (Haematoxylon)IBA
01/2020
1Neuroprotective AgentsIBA
01/2020
1Long Noncoding RNAIBA
01/2020
1EnzymesIBA
01/2020
1Eosine Yellowish-(YS) (Eosin)IBA
01/2020
1fasudil (AT 877)IBA
01/2020
1ImmunosorbentsIBA
01/2020
1Protein Kinases (Protein Kinase)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1Vascular Endothelial Growth Factor CIBA
09/2017
1Transcription Factor 4IBA
09/2017
1Biological ProductsIBA
09/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2017
1Peptide Transporter 1IBA
02/2017
1salicylhydroxamic acid (SHAM)IBA
02/2017
1GhrelinIBA
02/2017
1SulfatasesIBA
12/2016
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2016
1OligopeptidesIBA
11/2015
1SolutionsIBA
11/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015
1NAD (NADH)IBA
01/2015
1Cell-Free Nucleic AcidsIBA
01/2015
1Hepatitis B e AntigensIBA
01/2013
1Streptozocin (Streptozotocin)FDA Link
09/2012

Therapy/Procedure

1Oncolytic Virotherapy
01/2020
1Punctures
02/2017
1Ligation
02/2017
1Drug Therapy (Chemotherapy)
12/2016